(Q46250438)

English

Assessment of the CYP3A-mediated drug interaction potential of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy volunteers

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19004846

Assessment of the CYP3A-mediated drug interaction potential of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy volunteers (English)

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19004846

author name string

Rajesh Krishna

1

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19004846

Arthur J Bergman

2

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19004846

Bo Jin

3

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19004846

Amit Garg

4

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19004846

Brad Roadcap

5

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19004846

Rita Chiou

6

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19004846

James Dru

7

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19004846

Josee Cote

8

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19004846

Tine Laethem

9

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19004846

Regina W Wang

10

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19004846

Varsha Didolkar

11

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19004846

Eva Vets

12

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19004846

Keith Gottesdiener

13

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19004846

John A Wagner

14

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19004846

publication date

11 November 2008

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19004846

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19004846

49

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19004846

1

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19004846

80-87

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19004846

Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone

1 reference

https://api.crossref.org/works/10.1177%2F0091270008326718

21 January 2018

Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies

1 reference

https://api.crossref.org/works/10.1177%2F0091270008326718

21 January 2018

Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole.

1 reference

https://api.crossref.org/works/10.1177%2F0091270008326718

21 January 2018

A potentially hazardous interaction between erythromycin and midazolam.

1 reference

https://api.crossref.org/works/10.1177%2F0091270008326718

21 January 2018

Oral administration of a low dose of midazolam (75 microg) as an in vivo probe for CYP3A activity

1 reference

https://api.crossref.org/works/10.1177%2F0091270008326718

21 January 2018

Effects of ketoconazole on the polymorphic 4-hydroxylations of S-mephenytoin and debrisoquine

1 reference

https://api.crossref.org/works/10.1177%2F0091270008326718

21 January 2018

Interaction between tolbutamide and ketoconazole in healthy subjects

1 reference

https://api.crossref.org/works/10.1177%2F0091270008326718

21 January 2018

Effects of the antifungal agents on oxidative drug metabolism: clinical relevance

1 reference

https://api.crossref.org/works/10.1177%2F0091270008326718

21 January 2018

The effect of ketoconazole on the jejunal permeability and CYP3A metabolism of (R/S)-verapamil in humans

1 reference

https://api.crossref.org/works/10.1177%2F0091270008326718

21 January 2018

The Conduct of In Vitro and In Vivo Drug-Drug Interaction Studies: A PhRMA Perspective

1 reference

https://api.crossref.org/works/10.1177%2F0091270008326718

21 January 2018

Identifiers

10.1177/0091270008326718

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19004846

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19004846

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46250438&oldid=2102155876"